GLP-1 diet plan

A GLP-1 diet plan is a structured eating framework for patients taking semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). It works around the appetite suppression and slower gastric emptying these medications cause. The job of the plan is to protect protein intake, hydration and micronutrient status while total calories fall.

The targets are the same whichever agent the patient takes. Aim for 1.2 to 1.6 g of protein per kilogram of body weight each day. Spread it across five or six small meals at roughly 25 to 30 g each, plus protein-rich snacks. Fluid runs to about 2 to 2.5 liters daily unless the prescriber advises otherwise.

Below you will find each target explained, the foods that help, the foods that trigger nausea, and a sample week. The downloadable template turns all of it into a form your practice completes with the patient and stores on their record.

Key takeaways

A GLP-1 diet plan is built around appetite suppression and slower gastric emptying, which a standard weight-loss diet ignores.

Protein comes first, at 1.2 to 1.6 g per kilogram of body weight daily, spread across five or six small meals.

About 2 to 2.5 liters of fluid a day, plus soluble fiber, keeps constipation manageable.

Resistance training two or three times a week protects lean mass during rapid weight loss.

Storing the completed plan on the patient record keeps targets, triggers and review dates in one place.

What a GLP-1 diet plan is, and why it needs its own rules

A GLP-1 diet plan is a personalized framework that accounts for the appetite and gastric changes caused by GLP-1 receptor agonist therapy. These medications are FDA-approved for type 2 diabetes and for chronic weight management. They slow gastric emptying and strengthen satiety signaling, so patients feel full on much less food.

Without structured guidance, patients run into predictable problems. They take in too few calories and lose muscle, skip protein, or choose foods their stomach no longer tolerates. Practices running these programs at scale keep the protocol inside their weight loss clinic software, so targets and review dates sit on one record.

How the medication changes what a patient can eat

The first three months on GLP-1 therapy reset how hunger works. Appetite signals that once drove a second helping fade away. Portions shrink from a full dinner plate to a side serving.

Foods that used to feel comforting often turn unpleasant. Fried food, fatty meat and sugary desserts are the usual culprits, and many patients feel queasy after a few bites. Practitioners can help by reframing this early. The medication has changed the patient’s hunger signals, so eating well now takes planning rather than willpower.

These effects apply across the drug class. Our GLP-1 medication list sets out which brands are approved for diabetes and which are approved for weight management.

• Appetite suppression: many patients eat noticeably less, often around 20-30% fewer calories, though intake varies.
• Weaker food preferences: high-fat and high-sugar items lose their appeal or bring on nausea.
• Slower gastric emptying: food stays in the stomach longer, so large meals feel uncomfortably full.
• Steadier blood sugar: cravings for refined carbohydrates diminish and energy dips become less frequent.
• Constipation and fiber needs: slower digestion calls for more fluid and more soluble fiber.

What to eat, and why it works

GLP-1 nutrition centers on nutrient density and tolerance. Every calorie has to carry protein, fiber or micronutrients, because there are far fewer of them. The targets below are what the rest of the plan is built around.

The table below sorts the foods that make those numbers reachable.

Foods to avoid

Few foods are banned outright, but some reliably trigger side effects or stall progress. Patients find their own triggers by trial and observation, and the template gives the practice somewhere to record them.

• Fried and greasy foods: they worsen nausea, and slow digestion makes the heaviness last longer.
• High-sugar foods and drinks: they spike blood sugar and bring cravings back. Many patients also report a taste aversion to sweet foods on GLP-1 therapy.
• Carbonated beverages: they increase bloating and stomach distention, which makes nausea worse.
• Alcohol: it slows gastric clearance further, dehydrates, and loosens portion control.
• Very large meals: even a low-calorie large meal causes pain and nausea when the stomach empties slowly.
• Lactose, in sensitive patients: dairy can worsen constipation or stomach upset for some.

A sample seven-day meal plan

This week shows how small-volume meals fit around GLP-1 appetite suppression. As written, the days land near the lower end of the protein target. Most patients will need larger portions or an extra protein snack to reach 1.2 to 1.6 g per kilogram, so adjust it with them.

Protecting muscle mass during rapid weight loss

Weight lost on GLP-1 therapy is not all fat. DXA substudies from semaglutide and tirzepatide trials have reported lean mass at roughly 25% to 40% of the total lost, with wide variation between patients. Nutrition and training decide how much of that a patient keeps.

Protein targets: patients should take in 1.2 to 1.6 g of protein per kilogram of body weight daily. For a 100 kg patient, that is 120 to 160 g a day. Aim for roughly 25 to 30 g per meal, plus protein-rich snacks, to reach the daily total. A high-protein diet plan gives patients a starting structure when they fall short.

Resistance exercise: two or three strength sessions a week preserve muscle during weight loss. A patient portal can carry exercise guides and check-ins between appointments.

Micronutrient monitoring: very low intake risks deficiency in iron, B12, vitamin D and folate. Arrange periodic bloodwork, at least annually and sooner if intake is very low or symptoms appear. Supplementation such as B12 injections may be needed.

Managing nausea, constipation and other side effects through food

Most GLP-1 side effects ease within weeks, but they derail adherence while they last. Diet and hydration handle the majority of them without touching the dose.

• Nausea: eat small, frequent meals, about five or six a day, and stop at the first sign of fullness. Avoid greasy food, sip ginger tea, and leave three to four hours between meals.
• Constipation: aim for about 2 to 2.5 liters of fluid daily, roughly 8 to 10 glasses, unless the prescriber advises otherwise. Add soluble fiber from ground flaxseed, oats or prune juice.
• Diarrhea: loose stools are common early in therapy. Increase potassium-rich foods such as bananas and sweet potato, and keep electrolytes up.
• Acid reflux: eat slowly, avoid spicy and acidic foods, and wait two to three hours after eating before lying down.
• Appetite loss: when a patient cannot reach their protein or calorie target, raise it with the prescriber, because the dose may need adjusting.

Pabau, the practice management platform we build, keeps those notes on the patient record. Its digital intake forms let practitioners log side-effect patterns, adjust the plan, and escalate to the prescriber when symptoms persist.

Adapting the plan for PCOS, fatty liver and type 2 diabetes

GLP-1 medications reach beyond weight management. PCOS and NAFLD/MASLD are often treated off-label, while type 2 diabetes is an approved indication. The core dietary principles hold in each case, with a few condition-specific adjustments.

• PCOS: emphasize low-glycemic foods, inositol-rich foods such as legumes and nuts, and anti-inflammatory choices like oily fish and berries. Weight loss and improved insulin sensitivity may improve cycle regularity and ovulation.
• NAFLD/MASLD: limit added sugar and refined carbohydrates, and prioritize fiber, lean protein and omega-3 fats. Avoid alcohol. Weight loss with GLP-1 therapy is associated with reduced liver fat.
• Type 2 diabetes: coordinate glucose monitoring with the prescriber, since other medications may need adjusting. Keep carbohydrate intake steady across meals to limit hypoglycemia.

The American Diabetes Association Standards of Care recommends GLP-1 receptor agonists with proven cardiovascular benefit for adults with type 2 diabetes. That applies where cardiovascular disease is established or risk is high, or where obesity is present, independent of baseline HbA1c. A dietitian-led plan keeps medication and nutrition aligned with the indication being treated.

When to bring in a registered dietitian

A registered dietitian adds structured accountability, condition-specific expertise and problem-solving between appointments. Dietitian support is associated with better adherence and better nutritional adequacy than a generic meal plan on its own.

Practices that build dietitian reviews into the program close the loop. An initial assessment leads to a personalized plan, then check-ins every week or two, progress tracking, and adjustment as tolerance changes.

Recommend dietitian involvement when the patient has type 2 diabetes, PCOS or liver disease. The same applies to very low appetite, a history of eating disorders, or side effects severe enough to need the meals redesigned.

How to use the template in your practice

The downloadable plan is built for use from the first GLP-1 consultation onward. The workflow runs like this.

1. Initial assessment: complete the form with the patient at the first consultation. Record baseline appetite, food tolerance, nausea triggers and activity level.
2. Personalized plan: adapt the sample week and the food lists to the patient’s preferences, allergies and comorbidities.
3. Print and provide: hand over a printed copy, and store a digital version in the patient record for later reference.
4. Follow-up schedule: weeks 2, 8 and 16 are a suggested schedule rather than a standard. Set the dates around the prescriber’s titration plan and your local protocol, and log progress on a weight loss measurement chart.
5. Documentation: Pabau Scribe, our AI scribe, can draft the follow-up note after each dietitian review. Scribe usage runs on credits, so budget it alongside the rest of the program.

Automated reminders and portal access keep the patient moving between reviews, so a missed follow-up gets picked up rather than forgotten.

How Pabau keeps GLP-1 nutrition plans on record

Most practices hand the diet plan over on paper and hope it comes back. The protein target ends up in a consultation note, the review dates sit in a diary, and the side-effect history lives in the patient’s memory.

In Pabau, the plan is a form. The practitioner completes it on the patient record, so the targets stay visible at every review. Automated reminders book the follow-up appointments, and measurements chart against the baseline captured on day one.

The result is a GLP-1 program you can audit. You can see which patients missed a review, which ones are under their protein target, and which ones stopped the medication. That is the difference between running a weight-loss service and tracking one.

Run GLP-1 nutrition reviews from one record

Pabau schedules dietitian follow-ups, stores each patient’s diet plan on their record, and tracks weight and measurements over time. Your GLP-1 program stays documented from the first consultation to the last review.

Book a demo

Conclusion

A GLP-1 prescription without a diet plan leaves the hardest part to the patient. The medication decides how much they eat. The plan decides what those smaller meals contain.

Hit the protein target, keep fluid up, and add two or three strength sessions a week. Patients who manage that lose weight with less muscle loss and fewer side effects along the way. The ones who do not tend to stall around month four and blame the drug.

Hand every patient the template at the first consultation, then set the review dates before they leave the room. Book a demo to see how Pabau keeps GLP-1 diet plans, reviews and measurements on one patient record.

Continue your research

Screening a patient before you prescribe? Ozempic questionnaire walks through the history, contraindications and goals worth capturing at the first visit.

Need consent paperwork for tirzepatide? Informed consent for tirzepatide treatment covers the risks, side effects and monitoring a patient has to acknowledge.

Treating patients with very small stomach capacity? Bariatric food list groups foods by stage and texture, which transfers well to GLP-1 patients who cannot finish a meal.

Building a case for a GLP-1 service? GLP-1 statistics collects the prescribing, adherence and outcome figures behind the demand.

Want something practical to send home? Grocery list for weight loss turns the food categories above into a shopping list patients can use straight away.

Frequently asked questions